查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1784172

全球皮下避孕植入市場

Subdermal Contraceptive Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 281 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球皮下避孕植入物市場規模將達到 16 億美元

全球皮下避孕植入市場規模預計在2024年達到11億美元，預計在分析期內（2024-2030年）將以6.7%的複合年成長率成長，到2030年將達到16億美元。依托孕烯植入是本報告分析的細分市場之一，預計其複合年成長率將達到7.9%，到分析期結束時達到11億美元。levonorgestrel植入細分市場在分析期間的複合年成長率預計為4.6%。

美國市場規模估計為 2.96 億美元，中國市場預計複合年成長率為 10.8%

美國皮下避孕植入物市場規模預計在2024年達到2.96億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到3.377億美元，在2024-2030年的分析期內，複合年成長率為10.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.3%和6.6%。在歐洲，預計德國市場的複合年成長率為4.5%。

全球皮下避孕植入市場—主要趨勢與促進因素摘要

為什麼皮下植入比傳統避孕方法更受歡迎？

植入埋植避孕藥在全球的快速普及，主要得益於育齡女性對長效可逆避孕藥 (LARC) 的日益偏好。與每日口服避孕藥或其他短期避孕方法（例如貼片和注射）不同，皮下植入只需一次植入即可提供三至五年的避孕效果，顯著降低了使用者的錯誤操作風險，並提高了整體避孕效果。隨著人們對生殖權利和避孕選擇的認知和教育程度的提高，皮下埋植避孕藥市場正在蓬勃發展，尤其是在醫療保健可近性不斷提高的新興市場。此外，世界衛生組織 (WHO)、聯合國人口基金 (UNFPA) 和美國國際開發署(USAID) 等組織發起的公共衛生計劃，正在積極推動在高生育率和避孕資源匱乏的地區使用植入。與避孕器避孕器(IUD) 相比，皮下植入侵入性較小，且無需植入子宮，因此成為未生育女性的首選。植入維護成本低、隱蔽性強且可逆性強，正在改變人們對避孕的看法，使其更注重便利性、自主性和長期規劃。因此，這些避孕設備不僅在受過良好教育的都市區中越來越受歡迎，而且透過政府和非政府組織支持的項目，也擴大覆蓋農村和服務不足的地區。

醫療保健政策和國際宣傳活動如何加速採用？

政府衛生政策和國際宣傳活動在加速採用皮下避孕植入方面發揮了核心作用，特別是在計劃生育需求未滿足的地區。在中低收入國家 (LMIC)，在永續目標 (SDG) 等框架下實現全民生殖保健的努力刺激了避孕植入物的大規模採購和補貼分發。 FP2030夥伴關係和全球捐助聯盟等舉措已經與製造商達成了優惠的價格協議，確保全球數百萬女性能夠負擔得起或免費使用植入。各國政府，特別是撒哈拉以南非洲和東南亞的政府，正在將皮下植入納入公共衛生計劃，為社區衛生工作者提供培訓，並擴大推廣和信任。同時，在已開發國家，圍繞女性健康、性別平等和生殖自主權的政策轉變導致 LARC 被保險覆蓋，並在青少年和年輕人中廣泛採用。學校和診所進行的宣傳宣傳活動，以及透過遠端醫療和藥房模式擴大服務可近性，正在確保更多人獲得資訊和服務。這些協調一致的政策和計劃工作正在減少污名化，改善服務可近性，並賦能女性，使她們能夠就自身生殖健康做出明智的選擇。

技術創新是否改善了設備設計和接受度？

植入設計和插入方法的技術創新使其對醫護人員和患者更具吸引力、更安全、更易於使用。市場正轉向新一代植入，其桿更細、更靈活，更易於插入和取出，從而減少不適感。生物可吸收材料和荷爾蒙釋放機制的進步使得活性藥物（例如依托孕烯）的輸送更加一致和可控，從而提高了療效並減少了副作用。器械製造商也在開發智慧植入套件，以縮短手術時間和降低複雜性，這進一步鼓勵醫療保健提供者提供此類選擇。研究還著重於數位化或可追蹤的植入包含微晶片或RFID（無線射頻識別）標籤，用於儲存給藥資訊並方便患者追蹤。此外，人們越來越重視具有文化敏感性的包裝和說明材料，以提高其在不同社會文化背景下的接受度。由於在某些地區，取出仍然是一個問題，因此正在努力確保培訓項目同樣注重植入物插入和安全及時取出。所有這些技術進步都使設備更加以使用者為中心，從而提高患者滿意度並擴大各個醫療生態系統的市場範圍。

全球範圍內植入需求不斷成長的原因是什麼？

皮下避孕植入物市場的成長受到多種因素的驅動，這些因素源於生殖健康趨勢、醫療保健可近性、人口結構變化和醫療創新。全球對有效、低維護避孕措施的需求不斷成長是一個主要促進因素，尤其是對於那些尋求計劃生育自主權而又不想面臨每日堅持挑戰的女性而言。都市區和農村的年輕一代對謹慎的長期避孕解決方案越來越感興趣，而植入非常適合這一特點。在數據和教育宣傳活動的支持下，人們越來越意識到延遲或間隔懷孕的健康和經濟效益，這影響更多女性選擇長效避孕方法。此外，政府和非政府組織支持的生殖健康計畫的廣泛採用，使更多社會經濟群體更容易獲得和負擔得起這些植入。從醫療保健提供者的角度來看，與其他方法相比，植入目前越來越受歡迎，因為其給藥方案簡化、手術時間更短、後續需求更少。該裝置本身的技術改進，包括更長的持續時間、更佳的激素輸送以及更便捷的移除，正在提升消費者的信心。世界各地的監管機構也正在迅速核准和採用新的模式，以認知到其公共衛生價值。最後，人們對計劃生育的文化態度的轉變以及女性受教育和就業參與率的提高，強化了生殖自主權的重要性，使皮下植入成為現代避孕護理中一個引人注目的解決方案。

部分

產品（依托孕烯植入、levonorgestrel植入）、通路（醫院、婦科診所、社區健康中心、其他）

受訪公司範例

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP33069

Global Subdermal Contraceptive Implants Market to Reach US$1.6 Billion by 2030

The global market for Subdermal Contraceptive Implants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Etonogestrel Implant, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Levonorgestrel Implant segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$296.0 Million While China is Forecast to Grow at 10.8% CAGR

The Subdermal Contraceptive Implants market in the U.S. is estimated at US$296.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$337.7 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Subdermal Contraceptive Implants Market - Key Trends & Drivers Summarized

Why Are Subdermal Implants Gaining Favor Over Traditional Contraceptives?

Subdermal contraceptive implants are witnessing a notable surge in global adoption, largely due to the growing preference for long-acting reversible contraceptives (LARCs) among women of reproductive age. Unlike daily oral contraceptives or short-term methods like patches and injections, subdermal implants offer protection for three to five years with a single insertion, significantly reducing the risk of user error and increasing overall efficacy. The market is benefitting from increased awareness and education about reproductive rights and contraception options, particularly in developing regions where access to healthcare is improving. Furthermore, public health initiatives by organizations such as the World Health Organization (WHO), UNFPA, and USAID are actively promoting the use of implants in regions with high fertility rates and limited access to contraceptive resources. Compared to intrauterine devices (IUDs), subdermal implants are less invasive and do not require uterine placement, making them a preferred option for women who may not have given birth. The minimal maintenance, discreet nature, and reversible function of implants are reshaping how contraception is viewed, shifting the narrative toward convenience, autonomy, and long-term planning. As a result, these devices are not only finding favor in urban, educated populations but also penetrating rural and underserved areas via government and NGO-supported programs.

How Are Healthcare Policies and Global Campaigns Accelerating Adoption?

Government healthcare policies and international campaigns are playing a central role in accelerating the adoption of subdermal contraceptive implants, especially in regions with unmet needs for family planning. In low- and middle-income countries (LMICs), the push toward universal access to reproductive healthcare under frameworks like the Sustainable Development Goals (SDGs) has spurred large-scale procurement and subsidized distribution of contraceptive implants. Initiatives such as the FP2030 partnership and global donor alliances have secured favorable pricing agreements with manufacturers, ensuring implants are affordable or free to millions of women worldwide. National governments, particularly in Sub-Saharan Africa and Southeast Asia, are integrating subdermal implants into public health programs and providing training for community health workers to increase outreach and trust. Meanwhile, in developed countries, policy shifts around women's health, gender equity, and reproductive autonomy have led to insurance coverage for LARCs, boosting their uptake among teenagers and young adults. School-based and clinic-based awareness campaigns, alongside expanding access via telehealth and pharmacy-based models, are ensuring that information and services reach broader populations. These coordinated policy and advocacy efforts are reducing stigma, improving access, and ensuring that women can make informed choices about their reproductive health-factors that are directly driving growth in the subdermal contraceptive implant market.

Are Technological Innovations Enhancing Device Design and Acceptance?

Yes, technological innovations in implant design and insertion methods are making subdermal contraceptive implants more appealing, safer, and easier to use for both healthcare providers and patients. The market is seeing a shift toward next-generation implants with thinner, more flexible rods that are easier to insert and remove with minimal discomfort. Advancements in bioresorbable materials and hormone release mechanisms are allowing for more consistent and controlled delivery of active agents like etonogestrel, thereby improving efficacy and reducing side effects. Device manufacturers are also developing smart insertion kits that reduce procedural time and complexity, further encouraging healthcare providers to offer the method. Some research efforts are focused on digital or trackable implants, incorporating microchips or radio-frequency identification (RFID) tags that can store dosing information and facilitate patient follow-up. Additionally, there’s an increased emphasis on culturally sensitive packaging and instruction materials, improving acceptance in diverse sociocultural contexts. As removal continues to be a concern in some regions, efforts are being made to ensure training programs focus equally on insertion and safe, timely removal. All these technological strides are making the devices more user-centric, thereby enhancing patient satisfaction and expanding market reach across different healthcare ecosystems.

What’s Behind the Rising Demand for These Implants Around the World?

The growth in the subdermal contraceptive implants market is driven by several factors rooted in reproductive health trends, healthcare access, demographic shifts, and medical innovation. The rising global demand for effective, low-maintenance contraception is a major driver, particularly among women seeking autonomy in family planning without daily adherence challenges. Younger populations in both urban and rural areas are showing increased interest in discreet, long-term contraceptive solutions, and implants fit that profile well. Growing awareness of the health and economic benefits of delayed or spaced pregnancies, supported by data and educational campaigns, is influencing more women to choose long-acting methods. Furthermore, the proliferation of government and NGO-supported reproductive health programs is making these implants more accessible and affordable across a wider range of socioeconomic groups. From a healthcare provider standpoint, implants are now favored due to simplified administration protocols, shorter procedure times, and fewer follow-up requirements compared to alternatives. Technological refinement in the devices themselves-such as longer duration, improved hormone delivery, and easier removability-is reinforcing consumer trust. Regulatory bodies worldwide are also fast-tracking approval and adoption of new models, recognizing their public health value. Lastly, shifting cultural attitudes toward family planning and increased female participation in education and the workforce are reinforcing the importance of reproductive autonomy, making subdermal implants a compelling solution in modern contraceptive care.

SCOPE OF STUDY:

The report analyzes the Subdermal Contraceptive Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Etonogestrel Implant, Levonorgestrel Implant); Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Subdermal Contraceptive Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Long-Acting Reversible Contraceptives (LARCs) Propels Growth in Subdermal Implant Adoption
    • Increased Government and NGO-Led Family Planning Initiatives Expand the Addressable Market in Emerging Economies
    • Shift Toward Female-Centric and Autonomous Contraceptive Methods Strengthens the Business Case for Implants
    • Affordability and High Efficacy of Subdermal Implants Drive Demand in Public Health and Low-Income Settings
    • Growing Acceptance of Minimal-Maintenance Birth Control Solutions Accelerates Demand Across Age Groups
    • Technological Advancements in Implant Materials and Insertion Devices Spur Innovation and Safety Improvements
    • Healthcare Provider Training and Outreach Programs Drive Adoption in Underserved and Rural Populations
    • Changing Social Norms and Awareness Campaigns Generate Demand for Discreet and Long-Term Contraception
    • Rising Insurance Coverage and Reimbursement Support Strengthens Uptake in Developed Markets
    • Expanded Use in Postpartum and Adolescent Contraception Creates New Opportunities for Market Penetration
    • Demand for Reversible and Fertility-Preserving Options Spurs Preference for Implantable Devices
    • Integration of Contraceptive Counseling into Primary Healthcare Systems Supports Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Subdermal Contraceptive Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Etonogestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Levonorgestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gynecology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Community Health Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION